Literature DB >> 22467494

Establishment of a human nonluteinized granulosa cell line that transitions from the gonadotropin-independent to the gonadotropin-dependent status.

Akira Iwase, Tohru Kiyono, Sachiko Takikawa, Maki Goto, Tomoko Nakamura, Yoshinari Nagatomo, Tatsuo Nakahara, Tomomi Kotani, Hiroharu Kobayashi, Mika Kondo, Shuichi Manabe, Fumitaka Kikkawa.   

Abstract

The ovary is a complex endocrine organ responsible for steroidogenesis and folliculogenesis. Follicles consist of oocytes and two primary steroidogenic cell types, the granulosa cells, and the theca cells. Immortalized human granulosa cells are essential for researching the mechanism of steroidogenesis and folliculogenesis. We obtained granulosa cells from a 35-yr-old female and immortalized them by lentivirus-mediated transfer of several genes so as to establish a human nonluteinized granulosa cell line (HGrC1). We subsequently characterized HGrC1 and investigated its steroidogenic performance. HGrC1 expressed enzymes related to steroidogenesis, such as steroidogenic acute regulatory protein, CYP11A, aromatase, and gonadotropin receptors. Stimulation with FSH increased the mRNA levels of aromatase, which consequently induced the aromatization of androstenedione to estradiol. Activin A increased the mRNA levels of the FSH receptor, which were synergistically up-regulated with FSH stimulation. HGrC1 also expressed a series of ligands and receptors belonging to the TGF-β superfamily. A Western blot analysis showed that bone morphogenetic protein (BMP)-4, BMP-6, and BMP-7 phosphorylated small mother against decapentaplegic (Smad)1/5/8, whereas growth differentiation factor-9 phosphorylated Smad2/3. BMP-15 and anti-Müllerian hormone phosphorylated Smad1/5/8 while also weakly phosphorylating Smad2/3. These results indicate that HGrC1 may possess the characteristics of granulosa cells belonging to follicles in the early stage. HGrC1 might also be capable of displaying the growth transition from a gonadotropin-independent status to gonadotropin-dependent one.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22467494     DOI: 10.1210/en.2011-1810

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

1.  Mutant FOXL2C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors.

Authors:  Stine E Weis-Banke; Mads Lerdrup; Daniela Kleine-Kohlbrecher; Faizaan Mohammad; Simone Sidoli; Ole N Jensen; Toshihiko Yanase; Tomoko Nakamura; Akira Iwase; Anthe Stylianou; Nadeem R Abu-Rustum; Carol Aghajanian; Robert Soslow; Arnaud Da Cruz Paula; Richard P Koche; Britta Weigelt; Jesper Christensen; Kristian Helin; Paul A C Cloos
Journal:  Cancer Res       Date:  2020-07-08       Impact factor: 12.701

2.  PAI-1 in granulosa cells is suppressed directly by statin and indirectly by suppressing TGF-β and TNF-α in mononuclear cells by insulin-sensitizing drugs.

Authors:  Kaori Yamada-Nomoto; Osamu Yoshino; Ikumi Akiyama; Akira Iwase; Yosuke Ono; Tomoko Nakamura; Miyuki Harada; Akitoshi Nakashima; Tomoko Shima; Akemi Ushijima; Yutaka Osuga; Russell Jeffrey Chang; Shunichi Shimasaki; Shigeru Saito
Journal:  Am J Reprod Immunol       Date:  2017-03-24       Impact factor: 3.886

3.  CYP51A1 induced by growth differentiation factor 9 and follicle-stimulating hormone in granulosa cells is a possible predictor for unfertilization.

Authors:  Tomoko Nakamura; Akira Iwase; B Bayasula; Yoshinari Nagatomo; Mika Kondo; Tatsuo Nakahara; Sachiko Takikawa; Maki Goto; Tomomi Kotani; Tohru Kiyono; Fumitaka Kikkawa
Journal:  Reprod Sci       Date:  2014-04-07       Impact factor: 3.060

4.  Reprogramming of Ovarian Granulosa Cells by YAP1 Leads to Development of High-Grade Cancer with Mesenchymal Lineage and Serous Features.

Authors:  Xiangmin Lv; Chunbo He; Cong Huang; Guohua Hua; Xingcheng Chen; Barbara K Timm; Victoria M Maclin; Abigail A Haggerty; Shelly K Aust; Denae M Golden; Bhavana J Dave; Yun-An Tseng; Li Chen; Hongbo Wang; Peichao Chen; David L Klinkebiel; Adam R Karpf; Jixin Dong; Ronny I Drapkin; Bo R Rueda; John S Davis; Cheng Wang
Journal:  Sci Bull (Beijing)       Date:  2020-03-30       Impact factor: 20.577

5.  Establishment and characterization of a PCOS and a normal human granulosa cell line.

Authors:  Zohreh Hashemian; Parvaneh Afsharian; Parvaneh Farzaneh; Poopak Eftekhari-Yazdi; Faezeh Vakhshiteh; Abdolreza Daneshvar Amoli; Ahmad Nasimian
Journal:  Cytotechnology       Date:  2020-09-28       Impact factor: 2.058

6.  FOXL2C134W-Induced CYP19 Expression via Cooperation With SMAD3 in HGrC1 Cells.

Authors:  Martina Belli; Nahoko Iwata; Tomoko Nakamura; Akira Iwase; Dwayne Stupack; Shunichi Shimasaki
Journal:  Endocrinology       Date:  2018-04-01       Impact factor: 4.736

7.  Primate-specific POTE-actin gene could play a role in human folliculogenesis by controlling the proliferation of granulosa cells.

Authors:  Yukiyo Kasahara; Satoko Osuka; Nobuyoshi Takasaki; Yoshihiro Koya; Natsuki Nakanishi; Tomohiko Murase; Tomoko Nakamura; Maki Goto; Akira Iwase; Hiroaki Kajiyama
Journal:  Cell Death Discov       Date:  2021-07-20

8.  Antioxidative effect of dietary flavonoid isoquercitrin on human ovarian granulosa cells HGL5 in vitro.

Authors:  A Kolesarova; K Michalcova; S Roychoudhury; S Baldovska; E Tvrda; J Vasicek; P Chrenek; L Sanislo; V Kren
Journal:  Physiol Res       Date:  2021-09-10       Impact factor: 1.881

Review 9.  Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors.

Authors:  Hsun-Ming Chang; Jie Qiao; Peter C K Leung
Journal:  Hum Reprod Update       Date:  2016-10-26       Impact factor: 15.610

10.  Estradiol Regulates mRNA Levels of Estrogen Receptor Beta 4 and Beta 5 Isoforms and Modulates Human Granulosa Cell Apoptosis.

Authors:  Alice Pierre; Anne Mayeur; Clémentine Marie; Victoria Cluzet; Jonathan Chauvin; Nelly Frydman; Michael Grynberg; Joelle Cohen-Tannoudji; Céline J Guigon; Stéphanie Chauvin
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.